Male hypogonadism
Also known as: Male testosterone deficiency, Androgen deficiency in men, Testicular hypofunction, Hypogonadotropic hypogonadism, Hypergonadotropic hypogonadism
Male hypogonadism is defined as the clinical failure of the testes to produce physiological levels of testosterone and/or adequate spermatozoa, resulting from primary testicular failure or secondary hypothalamic-pituitary dysfunction. Diagnosis requires clinical symptomatology concordant with repeated morning biochemical assays; isolated fatigue or reduced libido are insufficient for diagnosis. Aetiological factors include obesity, systemic illness, pharmaceutical side effects, and HIV-associated complications. In Traditional Chinese Medicine, intervention is strictly adjunctive, focused on managing constitutional symptoms and general wellbeing rather than providing testosterone replacement or fertility treatments. Current clinical literature lacks trials establishing the efficacy of acupuncture or Chinese herbal medicine for this condition. Experimental data on Ginsenoside Rf are restricted to murine and in vitro models, while microbiome and bibliometric analyses have not demonstrated therapeutic utility. Furthermore, observational data in cohorts living with HIV indicate that hormonal stabilisation follows the initiation of antiretroviral therapy, underscoring the necessity of adherence to conventional medical protocols.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain consistent sleep hygiene and undergo medical evaluation for obstructive sleep apnoea symptoms, including stertorous snoring, apnoeic episodes, or chronic diurnal somnolence.
- •Adhere to a sustainable regimen of aerobic and resistance exercise under medical supervision where indicated; avoid abrupt overtraining and extreme caloric restriction.
- •Prioritise balanced nutritional intake and gradual weight management over restrictive dietary protocols or unverified microbiome-based programmes.
- •Moderating alcohol consumption is advised. Avoid non-prescribed anabolic-androgenic steroids or 'testosterone boosters', and ensure fertility goals are discussed with a medical practitioner prior to commencing hormonal therapy.
Cautions & Contraindications
- •Do not recommend ginsenoside Rf, ginseng or a formula as a proven testosterone-raising treatment: reference 1 studied mice and cells, not clinical benefit, interactions or reproductive safety in men.[]
- •Do not interrupt antiretroviral therapy for acupuncture or herbs. Check each proposed herbal product with the HIV prescriber or pharmacist; reference 3 reports hormonal improvement during ART but does not evaluate herb–ART interactions.[]
- •Do not use microbiome testing, probiotics or gut-directed herbal treatment as an established replacement for endocrine or fertility care; reference 2 is a mechanistic review, not proof of treatment efficacy.[]
- •Defer needling through infected skin and review bleeding risk, anticoagulants and significant immunosuppression before treatment. These are general procedural precautions, not findings established by the supplied bibliography; reference 4 is contextual only.[]
When to reassess or seek care again
Review adjunctive care after 4–6 weeks using baseline and follow-up fatigue, libido and sleep scores, functional goals and adverse effects. Coordinate hormone monitoring with the treating clinician rather than inferring hormonal change from symptoms. Refer promptly for unconfirmed diagnosis, persistent sexual dysfunction, infertility, abnormal prolactin or gonadotrophins, or progressive symptoms. Stop ineffective or poorly tolerated adjunctive treatment; urgent findings override the review interval.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Biochemical pharmacology · 2026
- Asian biomedicine : research, reviews and news · 2026
- PloS one · 2025
- International journal of impotence research · 2024
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
